DVx, Inc. engages in the import and export of medical equipment and its related peripheral devices. It operates through the following segments: Arrhythmia, Ischemia, and Others. The Arrhythmia segment sells cardiac pacemaker, implantable cardioverter defibrillator, electrode catheter, and myocardial ablation catheter. The Ischemia segment provides automated injection contrast systems, excimer laser angioplasty systems, and coronary stents. The Others segment offers general surgery, neurosurgery, and products for the digestive systems. The company was founded by Makoto Wakabayashi on April 1, 1986 and is headquartered in Tokyo, Japan.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company